# Prevention Of Sudden Cardiac Death After Myocardial Infarction by Defibrillator Implantation

Study · id `cardio:ct-nct05665608` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05665608](<https://clinicaltrials.gov/study/NCT05665608>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT05665608

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease; Acute care and long-term living  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 3595 participants.

## Technical summary

Registry record NCT05665608. Randomized; no masking; primary purpose prevention. Start 2023-11-16 (actual); primary completion 2027-11-30 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose prevention
- Phase: Not applicable
- Enrolled: 3595 participants (planned count; ClinicalTrials.gov record NCT05665608, source copy `cardio:ctgov-nct05665608-2026-04-01`, retrieved 2026-10-26)
- Started: 2023-11-16 (actual) (ClinicalTrials.gov record NCT05665608, source copy `cardio:ctgov-nct05665608-2026-04-01`, retrieved 2026-10-26)
- Primary completion: 2027-11-30 (anticipated) (ClinicalTrials.gov record NCT05665608, source copy `cardio:ctgov-nct05665608-2026-04-01`, retrieved 2026-10-26)
- Completion: 2027-11-30 (anticipated) (ClinicalTrials.gov record NCT05665608, source copy `cardio:ctgov-nct05665608-2026-04-01`, retrieved 2026-10-26)
- Countries: Austria; Belgium; Czechia; Denmark; France; Germany; Hungary; Israel; Martinique; Netherlands; Poland; Spain; United Kingdom (ClinicalTrials.gov record NCT05665608, source copy `cardio:ctgov-nct05665608-2026-04-01`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05665608-2026-04-01`, retrieved 2026-10-26)

## The registry's words

- Brief title: Prevention Of Sudden Cardiac Death After Myocardial Infarction by Defibrillator Implantation
- Acronym: PROFID EHRA
- Condition: Sudden Cardiac Death
- Condition: Myocardial Infarction
- Intervention (Device): Implantable cardioverter-defibrillator (ICD)
- Intervention (Drug): Optimal Medical Therapy (OMT)
- Lead sponsor: Charite University, Berlin, Germany
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Heart attack (myocardial infarction) (`cardio:myocardial-infarction`)
- Registry condition terms include this condition: Sudden cardiac arrest (`cardio:sudden-cardiac-arrest`)
- Registry lists this organization as the lead sponsor: Charite University, Berlin, Germany (`cardio:org-charite-university-berlin-germany`)

## Provenance

Content hash: 9158800a616831e525f923b60223562fb5e4746bf1e9b93a7ab6ea247e8fd064
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
